IQVIA Holdings Inc.
IQV
Classement en actions
#557
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Prix de l'action
$267.50
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$44.03B
Changement (1 jour)
0.62%
Changement (1 an)
22.33%
Pays
US
Échange IQVIA Holdings Inc. (IQV)
Catégorie
Healthcare
Ratio P/E pour IQVIA Holdings Inc. (IQV)
Ratio P/E au October 2026 TTM : 32.24
Selon les derniers rapports financiers et le cours de l'action de IQVIA Holdings Inc., le ratio P/E actuel (TTM) est de 32.24. À la fin de l’année 2024, le P/E de l’entreprise était de 25.95.
Historique du ratio P/E pour IQVIA Holdings Inc. de 2010 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 32.24 | 13.18% |
| 2025 | 28.49 | 9.80% |
| 2024 | 25.95 | -17.14% |
| 2023 | 31.32 | -11.11% |
| 2022 | 35.23 | -36.98% |
| 2021 | 55.90 | -54.50% |
| 2020 | 122.85 | -22.16% |
| 2019 | 157.83 | 72.74% |
| 2018 | 91.37 | 460.90% |
| 2017 | 16.29 | -83.48% |
| 2016 | 98.60 | 351.94% |
| 2015 | 21.82 | 3.19% |
| 2014 | 21.14 | -16.72% |
| 2013 | 25.39 | -14.68% |
| 2012 | 29.76 | 36.17% |
| 2011 | 21.85 | -33.58% |
| 2010 | 32.90 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 36.15 | 12.13% |
US
|
|
| 39.77 | 23.35% |
US
|
|
| -290.26 | -1,000.17% |
US
|
|
| - | - |
CN
|
|
| 34.18 | 6.02% |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.